+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

HTCC: Broad Range Inhibitor of Coronavirus Entry



HTCC: Broad Range Inhibitor of Coronavirus Entry



Plos one 11(6): E0156552



To date, six human coronaviruses have been known, all of which are associated with respiratory infections in humans. With the exception of the highly pathogenic SARS and MERS coronaviruses, human coronaviruses (HCoV-NL63, HCoV-OC43, HCoV-229E, and HCoV-HKU1) circulate worldwide and typically cause the common cold. In most cases, infection with these viruses does not lead to severe disease, although acute infections in infants, the elderly, and immunocompromised patients may progress to severe disease requiring hospitalization. Importantly, no drugs against human coronaviruses exist, and only supportive therapy is available. Previously, we proposed the cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), and its hydrophobically-modified derivative (HM-HTCC) as potent inhibitors of the coronavirus HCoV-NL63. Here, we show that HTCC inhibits interaction of a virus with its receptor and thus blocks the entry. Further, we demonstrate that HTCC polymers with different degrees of substitution act as effective inhibitors of all low-pathogenic human coronaviruses.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057963921

Download citation: RISBibTeXText

PMID: 27249425


Related references

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor. Plos Pathogens 12(3): E1005531, 2016

Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. Journal of Virology 79(22): 14451-6, 2005

Identification of a broad-spectrum arenavirus entry inhibitor. Journal of Virology 82(21): 10768-10775, 2008

Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor. Journal of Virology 90(9): 4494-4510, 2016

CD4-BFFI: a novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency. Antiviral Research 83(3): 257-266, 2009

Biophysical approaches to entry inhibitor antivirals with a broad spectrum of action. Future Virology 9(3): 283-299, 2014

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences of the United States of America 102(22): 7988-7993, 2005

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proceedings of the National Academy of Sciences of the United States of America 111(34): 12516-12521, 2014

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. Mbio 3(6):, 2012

Broad-spectrum anti-human immunodeficiency virus (HIV) potential of a peptide HIV type 1 entry inhibitor. Journal of Virology 81(7): 3645-3648, 2007

Comparison between a Broad-Range Real-Time and a Broad-Range End-Point PCR Assays for the Detection of Bacterial 16S rRNA in Clinical Samples. Annals of Clinical and Laboratory Science 46(1): 18-25, 2016

TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. Antimicrobial Agents and ChemoTherapy 49(6): 2314-2321, 2005

1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. Viruses 10(6):, 2018

A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry. Journal of Receptor and Signal Transduction Research 36(2): 119-129, 2016

Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. Journal of Virology 74(14): 6377-6385, 2000